special comment: the wu-tang clan vs. pharma-bro: once upon a time in shaolin (VIDEO)

Okay, regularly scheduled reviews will be returning soon, but I had to do this, had to say something. Next up, some old business to cover, a few more regularly scheduled reviews, and then FINALLY year-end lists, so stay tuned!

special comment: the wu-tang clan vs. pharma-bro: once upon a time in shaolin

In March of 2014, the Wu-Tang Clan made an unexpected announcement: seven years after the release of their last album in 2007, they were putting together a new compilation record. Now it supposedly wasn't produced by the RZA, but it was still a double album of new Wu-Tang Clan, and what's more, the packaging was ornate: encased in a hand-crafted silver and nickel box that would tour the world through art galleries, museums, and music festivals before being sold to a single individual for an exorbitant price. Now sure, the rest of the world was still going to get a new Wu-Tang record titled A Better Tomorrow, that would be released around this time last year to mixed at best reviews, but for hardcore Wu-Tang fans, this was material that they desperately wanted to hear - and yet with the RZA's asking price in the millions, nowhere near enough money to hear it. Now there was originally going to be conditions built into a contract that the album could only be heard at listening parties and not shared or distributed, but eventually the group relaxed these terms so that the album couldn't be resold commercially, so there was a chance that one might be able to hear the album if it leaked.

And yet it doesn't seem like that is likely, because only a few days ago it was announced that The Wu - Once Upon A Time In Shaolin had been sold - to Martin Shkreli, a supposedly brilliant pharmaceutical executive who became infamous online for jacking up the price of an anti-parasitic drug named Daraphim from $13.50 to well over $750 - per pill. I should also add that this is a drug that's utilized for treating AIDS. Nicknamed 'Pharma-Bro' for his obnoxious attitude and confirming abhorrent stereotypes surrounding both pharmaceutical executives and hedge fund managers, Martin Shkreli participated in the online auction for the album and got it for two millions dollars - well under most of the RZA's reported asking prices. And as for the record, Shkreli has said he hasn't listened to the album yet and is 'saving it for a rainy day', or if 'Taylor Swift wanted to hear it or something like that'.